|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.961 USD | -2.16% |
|
-19.13% | -33.63% |
| May. 07 | Transcript : Rigel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| May. 07 | Earnings Flash (RIGL) RIGEL PHARMACEUTICALS Posts Q1 Revenue $29.5M, vs. Street Est of $31.5M | MT |
Rigel Pharmaceuticals, Inc. provided revenue guidance for the fourth quarter of 2022. For the quarter, the company expected to report total revenue of approximately $51.3 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.63% | 172M | |
| +3.88% | 111B | |
| +11.45% | 105B | |
| -12.55% | 22.34B | |
| -3.70% | 21.93B | |
| -6.03% | 18.59B | |
| -35.21% | 18.12B | |
| -10.67% | 16.96B | |
| +2.93% | 13.7B | |
| +36.73% | 12.45B |
RIGEL PHARMACEUTICALS, INC. 
